FDA grants Lilly's olomorasib breakthrough therapy status for pancreatic cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. AZN
2. SPY
3. SATL
4. SRRK
5. LYNX
6. DFTX
7. BBNX
8. ELMT
9. ORCL
10. AGMB

Go back to FDA grants Lilly's olomorasib breakthrough therapy status for pancreatic cancer

Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer

August 3, 2026 7:45 AM EDT

INDIANAPOLIS, Aug. 3, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration... More